Optimizing Benefits While Reducing Risks of Iron in Malaria Endemic Areas. Randomized, placebo controlled trial of daily oral therapy started concurrently (immediate iron ) or 28 days after (delayed iron) with antimalarial treatment in Ugandan children with uncomplicated malaria and iron deficiency.
This will be a longitudinal cohort study with a 5 year follow up where caregivers and children with the five most common forms of severe malaria that is cerebral malaria(CM), severe malarial anemia(SMA), malaria with repeated seizures(M/S), respiratory distress(RD), prostration(PR) and healthy community children(CC)from the same neighborhood or household.
GLOBAL HEALTH UGANDA
A Multi-Disciplinary Research Collaboration